Status | Study |
Completed |
Study Name: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2013-04-01 Interventions: Drug: NPB-01 Other Name: Intravenous immunoglobulin |
Completed |
Study Name: Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2012-06-19 Interventions: Drug: Fingolimod Drug: Placebo Comparator |
Completed |
Study Name: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) Condition: Chronic Inflammatory Demyelinating Polyneuropathy Polyradiculon Date: 2012-03-01 Interventions: Biological: IgPro20 |
Completed |
Study Name: Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2011-06-16 |
Withdrawn |
Study Name: High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2010-11-05 Interventions: Drug: Cyclophosphamide |
Completed |
Study Name: Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2010-08-18 Interventions: Biological: 10% liquid formulation of human immunoglobulin Other Name: IgPro10; Privigen |
Completed |
Study Name: Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Date: 2009-11-06 Interventions: Drug: Subcutaneous immunoglobulin The subcutaneous immunoglobulin is infused in the subcutaneous tissue |
Completed |
Study Name: Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy Condition: CIDP Chronic Inflammatory Demyelinating Polyneuropathy Date: 2009-08-19 Interventions: Drug: lipoic acid Subjects will be started on a single daily dose of 600 mg of alpha lipoic acid or plac |
Completed |
Study Name: Study of CIDP Patients During IVIG Treatment Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Date: 2006-03-20 Interventions: Drug: intravenous gammaglobulin individual dose |
Active, not recruiting |
Study Name: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2006-01-16 Interventions: Biological: hematopoietic stem cell transplantation Autologous hematopoietic stem cell transplantation |